Skip to main content

Tyrus Capital S.A.M.

SEC CIK
0001543065
Latest filing
Nov 14, 2023

AVIR holding history

Atea Pharmaceuticals, Inc. in every 13F filed by Tyrus Capital S.A.M., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVIR overviewAll 13F holders of AVIRFull Q3 2023 holdings

Shares (Q3 2023)
1,260,000
Value
$3.78M
% of portfolio
35.9%
Quarters held
4
Since Q4 2022
Holdings of AVIR by Tyrus Capital S.A.M., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20231,260,000$3.78M35.9%00.0%UnchangedHolders
Q2 20231,260,000$4.71M33.1%00.0%UnchangedHolders
Q1 20231,260,000$4.22M24.9%00.0%UnchangedHolders
Q4 20221,260,000$6.06M13.2%–No prior filingHolders